The designation means that the NgG vaccine, which is in a phase 2 trial, will receive expedited review by FDA officials.
Analysis of Neisseria gonorrhoeae isolates from 3 African countries finds high resistance to ciprofloxacin and emerging resistance determinants for azithromycin.
The trial is evaluating the efficacy of oral zoliflodacin compared with the standard regimen of ceftriaxone plus azithromycin.
State health officials say the strain, which had reduced susceptibility to the last remaining recommended antibiotic treatment, is a serious public health concern.
International travel may play a critical role in the spread of multidrug-resistant (MDR) sexually transmitted infections (STIs), according to a study published late last week in Travel Medicine and Infectious Disease.
Researchers in Austria are reporting the identification of a second strain of extensively drug-resistant (XDR) gonorrhea.
The World Health Organization (WHO) today issued a report highlighting the threat of healthcare-associated infections (HAIs) and the role that infection prevention and control (IPC) programs can play in reducing that threat.
Data suggest 4CMenB protection against gonorrhea and support the feasibility of a gonococcal vaccine.
The introduction of procalcitonin (PCT) testing at UK hospitals during the first wave of the COVID-19 pandemic was associated with an immediate but not sustained decline in antibiotic prescribing, researchers reported today in the Journal of Antimicrobial Chemotherapy.
A rapid, cartridge-based polymerase chain reaction (PCR) platform developed by scientists at Johns Hopkins University for detecting gonorrhea infections and providing antibiotic susceptibility results showed promising results in a study published this week in Science Translational Medicine.
